spacer
home > pmps > winter 2001 > digital printing for pharmaceutical packaging - a customer's perspective
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Digital Printing for Pharmaceutical Packaging - A Customer's Perspective

As digital printing becomes a more viable option for packaging, printing vendors are looking to the pharmaceutical industry as a lucrative market. There are several reasons why digital printing is suitable for pharmaceutical packaging:

The option of quick turnaround for printed materials is
especially attractive in an industry which is under increasing
pressure to bring products to launch

Frequent changes to packaging make any options which
reduce the inventory of printed materials very advantageous

Rapid safety changes are often necessary for
pharmaceutical products

While the cost of printed materials is not a major portion
of the cost of the product for large orders of pharmaceutical
products, this is not always true for short run, small volume
products.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Susan B. McNeely, Associate Engineering Consultant at Eli Lilly and Company in the US
Susan McNeely is a member of Eli Lilly and Company's corporate team, which provides technical support to Lilly packaging sites worldwide.
She is a Chemist by training and her previous assignments at Lilly include printed packaging development, pharmaceutical product development and quality assurance. Prior to joining Lilly, Susan worked at RCA and the University of Cincinnati Medical Center.

spacer
Susan B. McNeely
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Introducing Signant Health [Formerly CRF Bracket] and the Industry’s Most Comprehensive Patient-Centric Suite for Clinical Research

Philadelphia and London – June 10, 2019: CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, today launched as Signant Health (signanthealth.com). Uniting eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite, Signant makes it easier to participate in – and sites and study teams to run – clinical trials. This intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable sponsors and CROs to extend the reach of drug development, expand patient opportunities and improve data quality.
More info >>

White Papers

The Flexible Factory Concept: A flexible bioprocessing platform to meet the changing needs of biomanufacturing

GE Healthcare Life Sciences

For the past several years, the biopharma industry has been buffeted by dynamic market conditions that are rapidly reshaping manufacturing requirements. These factors include: • The rise of small-market pharmaceuticals that do not require the production scale of the previous “blockbuster” drug model • Increased titers and process productivity that generate more bulk-product within a much smaller manufacturing footprint • The emergence of biosimilars and continued evolution of healthcare reform, which will increasingly pressure drug pricing and require greater cost discipline • Greater competition and shorter patent protection timelines, which will further ratchet up time-to-market pressures • Tighter capital markets that will create heightened scrutiny for all new investment projects
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement